· By Sanofi Admin

Drug Development 101: Phase 2 Clinical Trials

Author: Kristin Schuhwerk, VP, Global Head of Clinical Operations, Sanofi
This past November, my colleague Paul Deutsch shared some valuable information about Phase 1 clinical trials, as part of our Drug Development 101 series. Today, I’d like to build on this information by providing some insight on what comes after Phase 1 clinical trials – Phase […]

VIEW FULL POST
 · By Sanofi Admin

Imagine – Innovate – Inspire: Science Offsite Celebrates Great Science for 20th Year

Jim Burns

This post was authored by Jim Burns, Head of North America R&D Hub for Sanofi.
Jim Burns
For the past twenty years, I’ve been part of an amazing tradition where Sanofi’s scientists come together to share their research and discoveries. This annual event, known as the Science Offsite, brings together scientists from our R&D community across all […]

VIEW FULL POST
 · By Sanofi Admin

Drug Development 101: Preclinical Research

Author: Doug Keller, Global Head of Preclinical Safety Development Projects
How much do you know about the types of studies that researchers need to conduct before a new therapy can be approved for use in humans?
Many are familiar with clinical trials, since they involve human volunteers. But before clinical trials can take place, each experimental treatment […]

VIEW FULL POST